Department of Public Health, Arcadia University, 450 Easton Rd, Glenside, PA, 19038, USA.
J Cancer Educ. 2023 Jun;38(3):738-751. doi: 10.1007/s13187-023-02273-0. Epub 2023 Feb 24.
In the USA, colorectal cancer (CRC) is the 2nd leading cause of cancer-related deaths. Certain groups in the USA are at an increased risk of developing CRC, including those with a genetic risk and family history. The purpose of this project was to synthesize primary and secondary prevention interventions for individuals who are at high risk of CRC due to family history or genetic predisposition. This study systematically reviewed articles from PubMed, Google Scholar, and EBSCO using specific search terms to find relevant articles. Sixteen articles were identified for full-text review, which were categorized as non-drug interventions (n = 7) and drug interventions (n = 9). Non-drug interventions focused primarily on increasing screening in those with a first-degree relative (FDR) with CRC or those with Lynch syndrome (LS). Interventions that increased CRC screening often had a tailored component and were otherwise varied in study designs and intervention type. Drug interventions focused on the use of NSAIDs on patients with familial adenomatous polyposis (FAP). Studies showed very little racial and ethnic diversity. Findings suggest that tailored interventions are particularly effective in increasing CRC screening, and greater diversity of sample is needed with respect to race and ethnicity.
在美国,结直肠癌(CRC)是癌症相关死亡的第二大主要原因。美国的某些群体患 CRC 的风险增加,包括有遗传风险和家族史的人群。本项目旨在综合针对因家族史或遗传易感性而 CRC 风险较高的个体的一级和二级预防干预措施。本研究使用特定搜索词系统地检索了 PubMed、Google Scholar 和 EBSCO 中的文章,以找到相关文章。确定了 16 篇全文进行审查,这些文章分为非药物干预(n=7)和药物干预(n=9)。非药物干预主要集中在增加有结直肠癌一级亲属(FDR)或林奇综合征(LS)的人的筛查上。增加 CRC 筛查的干预措施通常具有针对性组成部分,并且在研究设计和干预类型上有所不同。药物干预侧重于使用 NSAIDs 治疗家族性腺瘤性息肉病(FAP)患者。研究表明,种族和民族多样性很少。研究结果表明,有针对性的干预措施特别有效地增加了 CRC 筛查,并且需要在种族和民族方面增加样本的多样性。